Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome

Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome — Trials · CancerIndex

Clinical trials

Registered studies

72 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 19
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03874052	Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	recruiting	Phase 1	51	Jennifer SaultzOTHER	1	Sep 24, 2026	clinicaltrials
NCT03630991	Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy	recruiting	Phase 1	58	M.D. Anderson Cancer CenterOTHER	1	Sep 18, 2026	clinicaltrials